Krsnaa Diagnostics Past Earnings Performance
Past criteria checks 2/6
Krsnaa Diagnostics has been growing earnings at an average annual rate of 7.2%, while the Healthcare industry saw earnings growing at 28% annually. Revenues have been growing at an average rate of 17.5% per year. Krsnaa Diagnostics's return on equity is 8.2%, and it has net margins of 10.2%.
Key information
7.2%
Earnings growth rate
-8.9%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 17.5% |
| Return on equity | 8.2% |
| Net Margin | 10.2% |
| Next Earnings Update | 14 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Krsnaa Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 6,812 | 692 | 1,997 | 0 |
| 30 Jun 24 | 6,503 | 601 | 1,820 | 0 |
| 31 Mar 24 | 6,196 | 568 | 1,888 | 0 |
| 31 Dec 23 | 5,866 | 570 | 1,844 | 0 |
| 30 Sep 23 | 5,464 | 577 | 1,718 | 0 |
| 30 Jun 23 | 5,138 | 625 | 1,525 | 0 |
| 31 Mar 23 | 4,871 | 621 | 1,680 | 0 |
| 31 Dec 22 | 4,621 | 611 | 1,690 | 0 |
| 30 Sep 22 | 4,505 | 638 | 1,752 | 0 |
| 30 Jun 22 | 4,358 | 610 | 1,656 | 0 |
| 31 Mar 22 | 4,555 | 684 | 1,724 | 0 |
| 31 Dec 21 | 4,431 | 395 | 1,518 | 0 |
| 31 Mar 21 | 3,965 | 1,849 | 1,464 | 0 |
| 31 Dec 20 | 3,694 | 1,307 | 1,441 | 0 |
| 31 Mar 20 | 2,584 | -1,120 | 1,060 | 0 |
| 31 Mar 19 | 2,092 | -621 | 877 | 0 |
| 31 Mar 18 | 1,076 | -602 | 372 | 0 |
| 31 Mar 17 | 569 | -39 | 130 | 0 |
Quality Earnings: 543328 has a high level of non-cash earnings.
Growing Profit Margin: 543328's current net profit margins (10.2%) are lower than last year (10.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 543328 has become profitable over the past 5 years, growing earnings by 7.2% per year.
Accelerating Growth: 543328's earnings growth over the past year (20%) exceeds its 5-year average (7.2% per year).
Earnings vs Industry: 543328 earnings growth over the past year (20%) did not outperform the Healthcare industry 31.4%.
Return on Equity
High ROE: 543328's Return on Equity (8.2%) is considered low.